NEW YORK, NY (November 11, 2015) InterbrandHealth is pleased to announce an expanding commitment to its healthcare mission and vision with the appointment of Wes Wilkes as Chief Strategy Officer to enhance collaboration across the network. Wes will continue to be based in New York and report to InterbrandHealth CEO Jane Parker.
“Healthcare represents a vital and exciting opportunity for Interbrand and InterbrandHealth to harness our collective expertise across all of our offices, and as Chief Strategy Officer, Wes will be instrumental in accomplishing that,” said Jane. “This appointment is the direct result of Wes’s tireless spirit of innovation, leadership, and partnership in making our vision and mission come to life over the past few years, as well as an outsized contribution to our growth and development into new and lucrative areas.”
In his role as Chief Strategy Officer Wes will continue to lead the strategy practice cultivating and generating business and talent, while adding an objective of contributing to the refinement of InterbrandHealth’s strategic prowess across the organization. He serves as a senior client partner for many marquis clients going through transformational change and rebranding with a focus on corporate brand strategy, corporate and brand architecture, brand acquisition strategies and pre-launch product brand strategy development. Prior to being appointed Chief Strategy Officer, Wes most recently served as Executive Director, Global Strategy Practice. He joined InterbrandHealth in 2006 from Pfizer where he served as Director of Marketing.
Wes’s appointment follows Interbrand’s recent investment in strategic leadership and expansion of its Experience and Content Strategy practices. “These key leadership appointments underscore our investment in the future of Interbrand’s global efforts, service offerings and our commitment to true leadership within the industry,” said Jez Frampton, Interbrand’s Global Chief Executive Officer.